TOPEKA (KSNT) - Federal health officials report a company is recalling thyroid tablets sold nationwide as they could be much more potent than usual and may bring about health issues for people who use them. The Food and Drug Administration (FDA) reports that Vitruvias Therapeutics Inc.
Thyroid tables distributed nationwide are being recalled over concerns that the product could be overly potent and potentially cause symptoms related to an overactive thyroid, warns the U.S. Food and Drug Administration.
Drug company Vitruvias Therapeutics Inc. has issued a nationwide recall for thyroid tablets after it was found the medication could be “superpotent,” meaning the pills — meant to treat hypothyroidism — could potentially lead to hyperthyroidism if taken.
(WHTM) -- A thyroid medication has been recalled nationwide because the product could potentially be "super potent." According to the U.S. Food & Drug Administration (FDA), Vitruvias Therapeutics Inc. is voluntarily recalling one lot (Lot No.
A pharmaceutical company is recalling 3,655 thyroid tablets sold nationwide because they could be more potent than usual and may bring about health issues for people who use them.
Vitruvias Therapeutics is recalling one lot of Thyroid Tablets, USP 30 mg, distributed nationwide after testing found the medication could be more potent than intended
